Related Experiment Videos
Reply to A. J. Cmelak et al and B. Kalra et al
Sue S Yom1, Pedro A Torres-Saavedra1, Quynh-Thu Le1
1Sue S. Yom, MD, University of California San Francisco, San Francisco, CA; Pedro A. Torres-Saavedra, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; and Quynh-Thu Le, MD, Stanford University, Stanford, CA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Post-Radiation Dental Care Access Among Head and Neck Cancer Survivors: A Safety Net Perspective.
Laryngoscope investigative otolaryngology·2026
Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Artificial Intelligence (AI)-Assisted Human Epidermal Growth Factor Receptor 2 (HER2) Scoring in Breast Cancer: Diagnostic Agreement and Understanding Discordance.
Laboratory investigation; a journal of technical methods and pathology·2026
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
'Not very Responsive for Kaumātua': A Wānanga-Based Qualitative Study (Single-Group Design) of Māori Kaumātua and Māori Health Provider Experiences of Type 2 Diabetes Care.
Journal of racial and ethnic health disparities·2026
Mehanokemija v Evropi: od kod prihajamo in kje smo danes.
Acta chimica Slovenica·2026